Self-renewal and solid-tumor stem cells
- PMID: 15682169
- DOI: 10.1016/j.bbmt.2004.11.011
Self-renewal and solid-tumor stem cells
Similar articles
-
Epigenetic regulation of normal and cancer stem cells.Ann N Y Acad Sci. 2005 Jun;1044:90-3. doi: 10.1196/annals.1349.012. Ann N Y Acad Sci. 2005. PMID: 15958701 Review.
-
Common themes of dedifferentiation in somatic cell reprogramming and cancer.Cold Spring Harb Symp Quant Biol. 2008;73:171-4. doi: 10.1101/sqb.2008.73.041. Epub 2009 Jan 15. Cold Spring Harb Symp Quant Biol. 2008. PMID: 19150965 Review.
-
Stem cells in the etiology and treatment of cancer.Curr Opin Genet Dev. 2006 Feb;16(1):60-4. doi: 10.1016/j.gde.2005.12.008. Epub 2005 Dec 27. Curr Opin Genet Dev. 2006. PMID: 16377171 Review.
-
Roots and stems: stem cells in cancer.Nat Med. 2006 Mar;12(3):296-300. doi: 10.1038/nm1379. Nat Med. 2006. PMID: 16520777
-
Cancer stem cells: differentiation block or developmental back-tracking?Semin Cancer Biol. 2007 Jun;17(3):189-90. doi: 10.1016/j.semcancer.2006.05.002. Epub 2006 May 20. Semin Cancer Biol. 2007. PMID: 16806966 No abstract available.
Cited by
-
CXCR4 mediates the proliferation of glioblastoma progenitor cells.Cancer Lett. 2009 Feb 18;274(2):305-12. doi: 10.1016/j.canlet.2008.09.034. Epub 2008 Nov 12. Cancer Lett. 2009. PMID: 19008040 Free PMC article.
-
DEAD-box helicase 27 plays a tumor-promoter role by regulating the stem cell-like activity of human colorectal cancer cells.Onco Targets Ther. 2018 Dec 28;12:233-241. doi: 10.2147/OTT.S190814. eCollection 2019. Onco Targets Ther. 2018. PMID: 30643421 Free PMC article.
-
Inhibition of 5-lipoxygenase downregulates stemness and kills prostate cancer stem cells by triggering apoptosis via activation of c-Jun N-terminal kinase.Oncotarget. 2019 Jan 11;10(4):424-436. doi: 10.18632/oncotarget.13422. eCollection 2019 Jan 11. Oncotarget. 2019. PMID: 30728896 Free PMC article.
-
Spironolactone inhibits the growth of cancer stem cells by impairing DNA damage response.Oncogene. 2019 Apr;38(17):3103-3118. doi: 10.1038/s41388-018-0654-9. Epub 2019 Jan 8. Oncogene. 2019. PMID: 30622338
-
Anti-DLL4, a cancer therapeutic with multiple mechanisms of action.Vasc Cell. 2011 Aug 10;3:18. doi: 10.1186/2045-824X-3-18. Vasc Cell. 2011. PMID: 21831306 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources